# Blue7

Blue7 is a Multi Family Office based in Singapore, Singapore.

## Overview

- **Organization type:** Multi Family Office
- **Headquarters:** Singapore, Singapore
- **Region:** Asia
- **Address:** Singapore, Singapore
- **Founded:** 2016
- **Assets under management:** Undisclosed
- **Website:** blue7.io
- **LinkedIn:** https://www.linkedin.com/company/blue7-sg

## Regulatory record

- **Reports private funds:** No

## About

Blue7 was established in Singapore by Juanita FU and MA Hui Hsing. Both hold advanced degrees in life sciences and business; FU earned an MD from the University of Southern California and MA completed an MS in Biotechnology from Johns Hopkins. The office deploys capital across venture, private equity funds, and ESG equity strategies without a disclosed single-family wealth source. Blue7 targets Seed and Series A rounds in Asia. Confirmed positions include direct exposure to Foundation Healthcare Holdings alongside Seatown Holdings, East Ventures, EMTEK, Orbit Malaysia, and Citrine Capital. The firm also holds positions in Bittensor and Render Network. Allocations occur via direct co-investments, SPVs, fund-of-funds vehicles, and private credit. Geographic focus remains Asia with emphasis on ventures that combine technology and sustainability metrics. The team includes Denzyl KHOO on the investment side and Genevieve HENG as Senior Advisor. Blue7 maintains professional ties to the CAIA Association, CFA Institute, IIX Partner Network, and Global Private Capital Association. In February 2024 Suguna Sureshkumar delivered a keynote on Blockchain and AI at the Royal Investment Summit on behalf of the firm. Blue7 operates with a hybrid mandate that blends multi-family office capital with impact requirements. Co-founders retain GP roles in separate life-science vehicles while the office itself functions as an allocator rather than an operating company. This structure separates investment decisions from any single family branch.

## Sectors

- AgriTech & FoodTech
- Digital Health
- EdTech
- FinTech
- Circular Economy
- ClimateTech

## People

- Juanita FU — Co-Founder
- MA Hui Hsing — Co-Founder
- Valerina Sureshkumar — Co-Founder
- Sugandhi — Co-Founder

## Questions

### Who runs investment decisions at Blue7?

Co-founders Juanita FU and MA Hui Hsing oversee strategy. Denzyl KHOO serves on the investment team and Genevieve HENG acts as Senior Advisor.

### Does Blue7 participate in fund commitments or only direct deals?

Blue7 uses both structures. It commits to funds such as Patamar Fund II and executes direct co-investments including Foundation Healthcare Holdings.

### What investment stages does Blue7 typically target?

The firm focuses on Seed and Series A rounds in Asia.

### How is Blue7 related to Patamar Capital?

MA Hui Hsing previously served as Partner at Patamar Capital. Blue7 is an investor in Patamar Fund II.

### Where does Blue7 source deal flow?

Blue7 sources through direct founder relationships and co-investor networks that include East Ventures, EMTEK, and Seatown Holdings.

### Does Blue7 maintain philanthropic structures?

Blue7 allocates via philanthropic and mission-related vehicles. Specific recipient entities are not publicly detailed beyond scholarship and school support references.

### Which sectors does Blue7 explicitly prioritize?

Blue7 prioritizes AgriTech & FoodTech, Digital Health, EdTech, FinTech, Circular Economy, and ClimateTech alongside Web3 infrastructure.

## Related profiles

- [Blücher Verwaltungs](https://altss.com/profile/bl-cher-verwaltungs)
- [Blue7](https://altss.com/profile/blue7-pte-ltd)

---

Last updated: 2026-06-03T20:00:00.000Z

Canonical page: https://altss.com/profile/blue7

Maintained by Altss — https://altss.com — methodology: https://altss.com/methodology